Members of a committee for the European Parliament on Tuesday signed off on a new legislative overhaul that aims to make their continent more attractive for pharma companies, but that drug companies have said may end up doing the opposite. The new directive and regulation would make pharma companies eligible for a minimum regulatory data … Continue reading Pharma companies question new EU incentives as revamp advances